We are a healthcare-focused SPAC sponsored by HighCape Capital LP (HighCape), a growth equity investment firm based in New York and focused in the Life Sciences industry. Our management team is led by the founding partners of HighCape, Kevin Rakin and Matt Zuga. Additionally the other HighCape Partners will also be involved in the operations of the SPAC.

We have also assembled a team of directors and advisors with extensive executive and transactional experience in pharmaceutical, biotechnology, medical device and diagnostic companies.